Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansson, M.
Right arrow Articles by Serup, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansson, M.
Right arrow Articles by Serup, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2603-2609, 2004
© 2004 by the American Diabetes Association, Inc.

Artifactual Insulin Release From Differentiated Embryonic Stem Cells

Mattias Hansson1, Anna Tonning2, Ulrik Frandsen1, Andreas Petri1,3, Jayaraj Rajagopal4, Mikael C.O. Englund5, R. Scott Heller1, Joakim Håkansson2, Jan Fleckner3, Helen Nilsson Sköld2, Douglas Melton4, Henrik Semb2, and Palle Serup1

1 Department of Developmental Biology, Hagedorn Research Institute, Gentofte, Denmark
2 Department of Medical Biochemistry, Göteborg University, Göteborg, Sweden
3 Department of Molecular Genetics, Novo Nordisk A/S, Bagsvaerd, Denmark
4 Department of Molecular and Cellular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts
5 Cell Therapeutics Scandinavia, Göteborg, Sweden

Several recent reports claim the generation of insulin-producing cells from embryonic stem cells via the differentiation of progenitors that express nestin. Here, we investigate further the properties of these insulin-containing cells. We find that although differentiated cells contain immunoreactive insulin, they do not contain proinsulin-derived C-peptide. Furthermore, we find variable insulin release from these cells upon glucose addition, but C-peptide release is never detected. In addition, many of the insulin-immunoreactive cells are undergoing apoptosis or necrosis. We further show that cells cultured in the presence of a phosphoinositide 3-kinase inhibitor, which previously was reported to facilitate the differentiation of insulin+ cells, are not C-peptide immunoreactive but take up fluorescein isothiocyanate–labeled insulin from the culture medium. Together, these data suggest that nestin+ progenitor cells give rise to a population of cells that contain insulin, not as a result of biosynthesis but from the uptake of exogenous insulin. We conclude that C-peptide biosynthesis and secretion should be demonstrated to claim insulin production from embryonic stem cell progeny.


Address correspondence and reprint requests to Palle Serup, Ph.D., Department of Developmental Biology, Hagedorn Research Institute, Niels Steensens vej 6, DK-2820 Gentofte, Denmark. E-mail: pas{at}hagedorn.dk. Or to Henrik Semb, Section for Endocrinology, Lunds University, Lund, Sweden. E-mail: henrik.semb{at}endo.mas.lu.se


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Stem CellsHome page
H. J. Rippon, J. M. Polak, M. Qin, and A. E. Bishop
Derivation of Distal Lung Epithelial Progenitors from Murine Embryonic Stem Cells Using a Novel Three-Step Differentiation Protocol
Stem Cells, May 1, 2006; 24(5): 1389 - 1398.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
S. P. Raikwar, T. Mueller, and N. Zavazava
Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells
Physiology, February 1, 2006; 21(1): 19 - 28.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
P. Vaca, F. Martin, J. M. Vegara-Meseguer, J. M. Rovira, G. Berna, and B. Soria
Induction of Differentiation of Embryonic Stem Cells into Insulin-Secreting Cells by Fetal Soluble Factors
Stem Cells, February 1, 2006; 24(2): 258 - 265.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. K.C. Brolen, N. Heins, J. Edsbagge, and H. Semb
Signals From the Embryonic Mouse Pancreas Induce Differentiation of Human Embryonic Stem Cells Into Insulin-Producing {beta}-Cell-Like Cells
Diabetes, October 1, 2005; 54(10): 2867 - 2874.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Yoshida, F. Ishikawa, N. Kawano, K. Shimoda, S. Nagafuchi, S. Shimoda, M. Yasukawa, T. Kanemaru, H. Ishibashi, L. D. Shultz, et al.
Human Cord Blood-Derived Cells Generate Insulin-Producing Cells In Vivo
Stem Cells, September 1, 2005; 23(9): 1409 - 1416.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
N. Shiraki, C.-J. Lai, Y. Hishikari, and S. Kume
TGF-{beta} signaling potentiates differentiation of embryonic stem cells to Pdx-1 expressing endodermal cells
Genes Cells, June 1, 2005; 10(6): 503 - 516.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. Shi, L. Hou, F. Tang, W. Jiang, P. Wang, M. Ding, and H. Deng
Inducing Embryonic Stem Cells to Differentiate into Pancreatic {beta} Cells by a Novel Three-Step Approach with Activin A and All-Trans Retinoic Acid
Stem Cells, May 1, 2005; 23(5): 656 - 662.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. J. Rhodes
Type 2 Diabetes-a Matter of {beta}-Cell Life and Death?
Science, January 21, 2005; 307(5708): 380 - 384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.